ArticleAnnals of hematology2026

Balancing safety and efficacy of Bendamustine plus anti CD20 regimens in elderly patients (> 70 y) with follicular lymphoma: a tertiary academic center experience.

Mattia D'Antiga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.